Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study
Crossref DOI link: https://doi.org/10.1186/s12877-016-0371-6
Published Online: 2016-11-25
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lenox-Smith, Alan
Reed, Catherine
Lebrec, Jeremie
Belger, Mark
Jones, Roy W.
Funding for this research was provided by:
Eli Lilly and Company
License valid from 2016-11-25